Last synced on 18 April 2025 at 11:05 pm

Pulmonic Replacement Heart Valve

Page Type
Product Code
Definition
For open surgical replacement of malfunctioning pulmonic heart valve.
Physical State
Animal tissue valve that has three leaflets and a ring of either tissue or fabric (called the sewing ring) that accepts sutures for sewing into the patient's annulus.
Technical Method
after being sewn into annulus, the leaflets open and close at appropriate periods in the heart beat cycle to control the flow of blood.
Target Area
Sutured into the heart in the location where the native pulmonic valve used to reside (pulmonic valve annulus).
Regulation Medical Specialty
Cardiovascular
Review Panel
Cardiovascular
Submission Type
HDE - Humanitarian Device Exemption
Device Classification
F
Regulation Number
870.3925
GMP Exempt?
No
Summary Malfunction Reporting
Eligible
Implanted Device
Yes
Life-Sustain/Support Device
Yes
Third Party Review
Not Third Party Eligible

CFR § 870.3925 Replacement heart valve

§ 870.3925 Replacement heart valve.

(a) Identification. A replacement heart valve is a device intended to perform the function of any of the heart's natural valves. This device includes valves constructed of prosthetic materials, biologic valves (e.g., porcine valves), or valves constructed of a combination of prosthetic and biologic materials.

(b) Classification. Class III (premarket approval).

(c) Date premarket approval application (PMA) or notice of completion of a product development protocol (PDP) is required. A PMA or a notice of completion of a PDP is required to be filed with the Food and Drug Administration on or before December 9, 1987 for any replacement heart valve that was in commercial distribution before May 28, 1976, or that has on or before December 9, 1987 been found to be substantially equivalent to a replacement heart valve that was in commercial distribution before May 28, 1976. Any other replacement heart valve shall have an approved PMA or a declared completed PDP in effect before being placed in commercial distribution.

[45 FR 7907, Feb. 5, 1980, as amended at 52 FR 18163, May 13, 1987; 52 FR 23137, June 17, 1987]

Pulmonic Replacement Heart Valve

Page Type
Product Code
Definition
For open surgical replacement of malfunctioning pulmonic heart valve.
Physical State
Animal tissue valve that has three leaflets and a ring of either tissue or fabric (called the sewing ring) that accepts sutures for sewing into the patient's annulus.
Technical Method
after being sewn into annulus, the leaflets open and close at appropriate periods in the heart beat cycle to control the flow of blood.
Target Area
Sutured into the heart in the location where the native pulmonic valve used to reside (pulmonic valve annulus).
Regulation Medical Specialty
Cardiovascular
Review Panel
Cardiovascular
Submission Type
HDE - Humanitarian Device Exemption
Device Classification
F
Regulation Number
870.3925
GMP Exempt?
No
Summary Malfunction Reporting
Eligible
Implanted Device
Yes
Life-Sustain/Support Device
Yes
Third Party Review
Not Third Party Eligible

CFR § 870.3925 Replacement heart valve

§ 870.3925 Replacement heart valve.

(a) Identification. A replacement heart valve is a device intended to perform the function of any of the heart's natural valves. This device includes valves constructed of prosthetic materials, biologic valves (e.g., porcine valves), or valves constructed of a combination of prosthetic and biologic materials.

(b) Classification. Class III (premarket approval).

(c) Date premarket approval application (PMA) or notice of completion of a product development protocol (PDP) is required. A PMA or a notice of completion of a PDP is required to be filed with the Food and Drug Administration on or before December 9, 1987 for any replacement heart valve that was in commercial distribution before May 28, 1976, or that has on or before December 9, 1987 been found to be substantially equivalent to a replacement heart valve that was in commercial distribution before May 28, 1976. Any other replacement heart valve shall have an approved PMA or a declared completed PDP in effect before being placed in commercial distribution.

[45 FR 7907, Feb. 5, 1980, as amended at 52 FR 18163, May 13, 1987; 52 FR 23137, June 17, 1987]